Wilmington, DE -- (SBWIRE) -- 01/09/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding YRC Worldwide Inc. (NASDAQ:YRCW) and Acasti Pharma Inc. (NASDAQ:ACST).
YRC Worldwide Inc. (NASDAQ:YRCW) a company that through its subsidiaries, provides various transportation services primarily in North America is currently down (-11.47%) on 2,959,163 shares traded after Teamsters group said YRC Worldwide contract extension may be defeated. YRC Worldwide Inc. (NASDAQ:YRCW) is currently down (-64.86%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about YRC Worldwide Inc. (NASDAQ:YRCW)
Acasti Pharma Inc. (NASDAQ:ACST) a biopharmaceutical company that focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders is currently up (+1.43%) on 1,626,448 shares traded after Acasti Pharma announced FDA has cleared its IND submission to initiate a Pharmacokinetic trial of CaPre in the US. Acasti Pharma Inc. (NASDAQ:ACST) is currently up (+43.12%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Acasti Pharma Inc. (NASDAQ:ACST)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report